Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NHO Plans to Improve Domestic Clinical Trials
August 23, 2004
- Eisai to Triple Production of Aricept, Pariet at Kashima Plant
August 23, 2004
- BULLETIN
August 23, 2004
- Mr Komine of MPC Stresses Medicoeconomic Benefits of Zione
August 23, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 23, 2004
- DIAGNOSTIC NEWS IN BRIEF
August 23, 2004
- REGULATORY NEWS IN BRIEF
August 9, 2004
- Dainippon in Wide-ranging Effort to Rationalize Marketing Division
August 9, 2004
- Expansion of Indications Recommended for 6 Anti-cancer Combination Therapies
August 9, 2004
- Becoming a Global, Research-driven Pharma Company: Mr Komine of MPC
August 9, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
August 9, 2004
- JPMA Positive on Korosho Council on Ethical Drug Distribution
August 9, 2004
- Self-palpation, Mammography Recommended for Breast Cancer: Roche Diagnostics Seminar
August 9, 2004
- Chugai to Transfer OTC Drug Business to Lion
August 9, 2004
- UFT Postoperative Adjuvant Chemotherapy Effective against Rectal Cancer: Taiho Seminar
August 9, 2004
- Kobayashi Embarks on Reorganization Effort
August 9, 2004
- PRESS SEMINAR
August 9, 2004
- OTC NEWS IN BRIEF
August 9, 2004
- NEW PRODUCTS
August 9, 2004
- MEDICAL DEVICE NEWS IN BRIEF
August 9, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…